# Fate Therapeutics Inc: Form SCHEDULE 13D/A, filed Jul 3, 2025

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: SCHEDULE 13D/A
- Filed: 2025-07-03
- Accepted by EDGAR: Jul 3, 2025, 16:01 ET
- Period: not reported
- Accession: 0001104659-25-065772
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000110465925065772/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000110465925065772/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000110465925065772/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jul 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-065772. Last ingested by Listed: Nov 5, 2026, 19:31 ET. No prices; not investment advice.